Chemo 6 Flashcards

1
Q

What are the Bcr-Abl Tyrosine Kinase inhibitors?

What do they treat?

A
  • Imatinib and Dasatinib

- CML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how does Imatinib work?

A

it occupies the APT cofactor binding site on Bcr-Abl, inhibiting transfer of phosphate to tyrosine on substrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Dasatinib used for?

A

treatment of primary and imatinib resistant CML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the mechanism of imatinib resistance

A

-involves mutation of the ATP binding pocket to exclude imatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Imatinib targets what other tyrosine kinases

A

-c-kit and PDGFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dasatinib targets what other tyrosine kinases?

A

-Src family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Imatinib can be used for what cancer other than CML

A

GIST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dasatinib can be used for what other cancer other than CML

A

ALL with Ph chromosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

85% of GIST tumors contain oncogenic forms of what tyrosine kinases

A

-KIT or PDGFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What do you use for imatinib resistant GIST

A

Sunitinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the adverse drug reactions with imatinib

A

due to hepatic CYP450 - rifampin and St. John’s wort hasten the clearance of it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

HER2 overexpression

A

Breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What drugs inhibit only EGFR?

used for what cancer?

A
  • Gefitinib
  • Erlotinib

-NSCLC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What drug inhibits both EGFR and HER2?

What cancer?

A

Lapatinib

-Breast Cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what 2 drugs inhibit both PDGFR and VEGFR

A
  • sunitinib

- sorafenib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What cancers do you used sunitinib for?

A
  • GIST

- RCC

17
Q

What cancers do you use Sorafenib for

18
Q

What does Vemurafinib inhibit

A

-Mutant BRAF V600E

19
Q

what cancer is Vemurafenib used for

A

metastatic malignant melenoma

20
Q

What are the antibodies that target EGFR receptor?

what cancer?

A
  • Cetuximab (colorectal, head and neck)
  • Panitumumab (colorectal)

-don’t work if there is KRAS mutations

21
Q

What is the antibody that targets Her2 receptor?

what cancer?

A

Trastuzumab

breast with Her2 mutation

22
Q

What is the antibody that targets VEGF LIGAND?

what cancer?

A

Bevacizumab

RCC

23
Q

why are some cancers with Ras mutation not affected by certain tyrosine kinase inhibitors

A

they by pass that receptor and affect down stream signal

24
Q

What drug blocks angiogenesis used for advanced solid tumors

A

Bevacizumab

25
Bevacizumab has been removed from indication for what?
metastatic Breast cancer
26
why does RCC respond well to angiogenesis inhibitors, both drugs (Sunitinib and Sorafenib) and Antibody (Bevacizumab)
they arise from inactivating mutations of BHL which governs the degradation and clarance of HIFa . . so HIF accumulated and activates VEGF and PDGF . . so the angiogenesis inhibitors block VEGF
27
What is Rituxomab used for?
CD20+ B cell Lymphoma
28
Explain the mechanism of action dependent on the number of antibodies that bind? Why is this a problem?
- few: complement punches holes and flood cell leading to lysis - moderate: recruits NK, T cells, and macrophages which attack - Many: Self destruction, apoptosis chemo induced myelosuppression can neutralize subsequent antibody bases therapy